NasiaSafdarMD
Infectious Disease • Madison, WIAssistant Professor, Medicine, University of Wisconsin Medical School
Dr. Safdar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-0943Fax+1 608-265-8885
Education & Training
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2002 - 2003- University of Wisconsin Hospitals and ClinicsFellowship, Infectious Disease, 2000 - 2002
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1997 - 2000
Aga Khan Medical CollegeClass of 1995
Certifications & Licensure
WI State Medical License 1999 - 2025- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE Start of enrollment: 2008 Oct 01
- A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE) Start of enrollment: 2010 Jan 01
- Impact of Probiotics for Reducing Infections in Veterans: The IMPROVE Study Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 159 citationsRisk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.Nasia Safdar, Adnan Said, Ronald E. Gangnon, Dennis G. Maki
JAMA. 2002-08-28 - 167 citationsEffectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.Tamara Pilishvili, Ryan Gierke, Katherine E. Fleming-Dutra, Jennifer L. Farrar, Nicholas M. Mohr
The New England Journal of Medicine. 2021-09-22 - 179 citationsAssociation Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.Jing Sun, Qulu Zheng, Vithal Madhira, Amy L Olex, Alfred J Anzalone
JAMA Internal Medicine. 2022-02-01
Journal Articles
- Fecal Microbiota Transplantation for the Treatment of Recurrent and Severe Clostridium Difficile Infection in Solid Organ Transplant Recipients: A Multicenter ExperienceRaj Vuppalanchi, Adam Ehrlich, Michael Smith, Asif Sharfuddin, Nasia Safdar, Nirmal Kaur, Elizabeth Ann Misch, Monika Fischer, Ann Flynn, Vincent Ganapini, Michael H W..., American journal of transplantation
- Research Agenda for Microbiome Based Research for Multidrug-Resistant Organism Prevention in the Veterans Health Administration SystemDale N Gerding, Loreen Herwaldt, Daniel J Diekema, Nasia Safdar, Matthew Samore, Infection Control and Hospital Epidemiology
- Setting the Research Agenda for Preventing Infections from Multidrug-Resistant Organisms in the Veterans Health AdministrationEli N Perencevich, Nasia Safdar, Infection Control and Hospital Epidemiology
Authored Content
- Hospital-Acquired Infections Are Rising – Here’s How to Protect Yourself in Health Care SettingsJuly 2024
- Using Virus Sequencing to Determine Source of SARS-CoV-2 Transmission for Healthcare WorkerAugust 2020
- The Wrong Frame of MindMay 2018
Press Mentions
- Hospital-Acquired Infections Are Rising – Here’s How to Protect Yourself in Health Care SettingsJuly 26th, 2024
Why a Coronavirus-Flu ‘Twindemic’ May Never HappenApril 8th, 2022- Ivermectin Does Not Prevent COVID-19 Hospitalization, Study FindsMarch 31st, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
